COVID-19 as a potential trigger for mirror syndrome: exploring an infectious etiology in a rare obstetric triad
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20260570Keywords:
Polycystic ovarian syndrome, Coronavirus disease 2019, Premature prelabour rupture of membranes, Reverse transcriptase polymerase chain reaction, Computerised tomographyAbstract
Mirror syndrome (Ballantyne's syndrome)—the triad of maternal edema, fetal hydrops, and placental hydrops—is a sporadic, life-threatening condition. Its etiology is diverse, including infections, isoimmunization, and fetal anomalies. This case report aims to explore and highlight a possible correlation between COVID-19 infection and the precipitation of mirror syndrome in a primigravida. In this case, a 25-year-old primigravida (PCOS history) presented to OPD at 28 weeks 4 days gestation with dyspnea and grade IV edema/anasarca. Ultrasound and MRI confirmed fetal hydrops (ascites, pleural effusion), polyhydramnios (Liquor 25-26 cm), and placentomegaly, fulfilling the diagnostic criteria for mirror syndrome. Further evaluation revealed maternal bilateral pleural effusion and consolidation, confirmed as a new-onset COVID-19 infection by CT and RT-PCR. Due to PPROM, the pregnancy was terminated, resulting in a stillbirth. Mirror syndrome's pathogenesis is thought to involve trophoblastic damage and endothelial dysfunction, similar to preeclampsia. Given that COVID-19 infection is known to induce systemic inflammation, coagulopathy, and endothelial injury, the timing of the maternal infection in this case suggests a potential infectious etiology. While a direct causal link requires further study, this case supports the hypothesis that COVID-19 may act as a trigger, contributing to the angiogenic-antiangiogenic imbalance implicated in the syndrome. This case highlights an unusual presentation of mirror syndrome coinciding with acute maternal COVID-19 infection. Due to the high morbidity/mortality of mirror syndrome, we advise wider screening for this condition in COVID-19 positive pregnant patients, and vice versa, to ensure early detection and prompt, etiology-based management.
References
Mogharbel H, Hunt J, D'Souza R, Hobson SR. Clinical presentation and maternal-fetal outcomes of Mirror Syndrome: A case series of 10 affected pregnancies. Obstet Med. 2022;15(3):190-4. DOI: https://doi.org/10.1177/1753495X211058043
Chen R, Liu M, Yan J, Chen F, Han Q, Zheng L, et al. Clinical characteristics of mirror syndrome: a retrospective study of 16 cases. J Obstet Gynaecol. 2021;41(1):73-6. DOI: https://doi.org/10.1080/01443615.2020.1718621
Sichitiu J, Alkazaleh F, de Heus R, Alfirevic Z, van den Berg PP, Tibboel D, et al. Maternal “mirror” syndrome: evaluating the benefits of fetal therapy. Prenat Diagn. 2024;44:979-87. DOI: https://doi.org/10.1002/pd.6589
Gavin NR, Forrest AD, Rosner M, Miller JL, Baschat AA. The role of fetal therapy in the management of mirror syndrome: a narrative review. J Matern Fetal Neonatal Med. 2024;37(1):2345307. DOI: https://doi.org/10.1080/14767058.2024.2345307
Jung E, Romero R, Yeo L, Gomez-Lopez N, Chaemsaithong P, Jaovisidha A, et al. The etiology of preeclampsia. Am J Obstet Gynecol. 2022;226(2):S844-66. DOI: https://doi.org/10.1016/j.ajog.2021.11.1356
Han Z, Chen X, Wang Q, Zhou J, Guo Y, Hou H, et al. Clinical characteristics and risk factors of mirror syndrome: a retrospective case-control study. BMC Pregnancy Childbirth. 2021;21(1):660. DOI: https://doi.org/10.1186/s12884-021-04143-3
Nau C, Esposito MA, Chen KK, Bowyer L. Mirror Syndrome. Glob Libr Womens Med. 2021. DOI: https://doi.org/10.3843/GLOWM.415763